Comment on "Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors".
Indiana University School of Medicine, Indianapolis, Indiana.
Kathleen E
KE
Gilbert
Georgia Regents University Medical College of Georgia, Augusta, Georgia.
Iviensan F
IF
Manalo
Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, California. Electronic address: jashinwu@hotmail.com.
Jashin J
JJ
Wu
D001691:Biological Therapy / Q000009:adverse effects*; D003141:Communicable Diseases / Q000150:complications* / Q000175:diagnosis*; D006801:Humans; D012871:Skin Diseases / Q000150:complications* / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D014409:Tumor Necrosis Factor-alpha